This story was originally published by Epicenter NYC. Sign up for their newsletters here. Ed Manchess can’t wait for the ...
Collaboration to evaluate monoclonal antibody as first-in-class treatment in this settingREDWOOD CITY, Calif. and HOUSTON, ...
Advocates say harm reduction isn’t just about clean needles or naloxone kits — it’s about meeting people where they are. During the holidays, that connection can save lives.